VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Technical Scanner
RSI, Moving averages & volume momentum signals
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
Minervini — VCPContraction bases in Stage 2 uptrends
Minervini — Trend TemplateFull 8-rule Stage 2 screen
O'Neil — Cup with HandleBase breakouts with RS leadership
O'Neil — CANSLIM LeadersGrowth leaders with RS ≥ 85
Qullamaggie — High Tight FlagsPower plays after a large advance
Qullamaggie — Momentum Leaders1/3/6-month strength leaders
Livermore — Pivotal PointsMulti-touch resistance breakouts
View All Playbooks...
Breakouts
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
Breakouts
WatchlistPricing
Ctrl K
Pricing
CTXR
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsCompareWatchlist
CTXRCitius Pharmaceuticals, Inc.
$0.53$6M
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksCTXRQuarterly Balance Sheet

Citius Pharmaceuticals, Inc. (CTXR) Quarterly Balance Sheet

120+ quarters historyFree accessUpdated daily

Citius Pharmaceuticals, Inc. (CTXR) quarterly balance sheet — complete assets, liabilities & equity history

Income StatementBalance SheetCash FlowRatios

CTXR Balance Sheet

Quarterly statement

CTXR Balance Sheet

Citius Pharmaceuticals, Inc. (CTXR) balance sheet — 15-year assets, liabilities & shareholders' equity history

AnnualQuarterly
MetricQ3'26Q2'26Q1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21
Total Current Assets43.33M31.69M37.95M27.93M24.61M18.37M18.33M14.22M28.01M21.57M28.21M34.37M41.11M34.9M42.32M44.56M50.83M58.26M67.94M72.81M
Cash & Short-Term Investments17.01M4.59M7.72M4.25M6.09M26.41K1.1M3.25M17.91M12.56M20.35M26.48M33.28M29.07M36.89M41.71M48.04M55.76M65.42M70.07M
Cash Only17.01M4.59M7.72M4.25M6.09M26.41K1.1M3.25M17.91M12.56M20.35M26.48M33.28M29.07M36.89M41.71M48.04M55.76M65.42M70.07M
Short-Term Investments00000000000000000000
Accounts Receivable686.24K1.08M4.05M00000000000000000
Days Sales Outstanding53.77138.4194.45-----------------
Inventory22.63M22.66M22.64M22.29M17.21M15.34M14.38M8.27M000000000000
Days Inventory Outstanding931.44994.761.52K29.29K35.8K--4.88K------------
Other Current Assets00000000000000000000
Total Non-Current Assets98.92M100.85M102.45M103M103.07M103.11M102.38M102.43M69.08M69.14M69.19M69.24M69.29M69.34M69.39M69.44M69.48M69.53M69.57M69.61M
Property, Plant & Equipment753.04K794.52K835.18K818.69K880.73K922.1K191.41K246.25K299.93K352.78K404.85K455.86K505.83K554.84K602.99K650.17K696.42K741.77K786.24K829.85K
Fixed Asset Turnover1.93x2.05x4.77x----0.57x------------
Goodwill9.35M9.35M9.35M9.35M9.35M9.35M9.35M9.35M9.35M9.35M9.35M9.35M9.35M9.35M9.35M9.35M9.35M9.35M9.35M9.35M
Intangible Assets88.79M90.51M92.23M92.8M92.8M92.8M92.8M92.8M59.4M59.4M59.4M59.4M59.4M59.4M59.4M59.4M59.4M59.4M59.4M59.4M
Long-Term Investments0000000000044.91M00000000
Other Non-Current Assets38.06K207.31K38.06K38.06K38.06K38.06K38.06K38.06K38.06K38.06K38.06K38.06K38.06K38.06K38.06K38.06K38.06K38.06K38.06K38.06K
Total Assets142.26M132.54M140.39M130.94M127.68M121.48M120.7M116.65M97.09M90.71M97.4M103.61M110.4M104.24M111.71M114M120.32M127.79M137.52M142.43M
Asset Turnover0.01x0.01x0.03x----0.00x------------
Asset Growth %11.42%9.1%16.31%12.25%31.5%33.92%23.93%12.59%-12.06%-12.98%-12.81%-9.11%-8.24%-18.43%-18.77%-19.96%-17.93%-5.11%289.43%225.38%
Total Current Liabilities51.65M55.02M38.21M44.91M51.84M49.88M44.81M35.81M4.15M4.17M5.58M5.78M5.79M6.21M4.54M4.53M4.46M4.02M7.34M3.98M
Accounts Payable8.04M9.45M11.02M13.69M10.09M9.37M7.36M4.93M1.66M2.67M2.65M2.93M3.08M2.73M1.54M1.17M1.69M1.71M1.79M1.28M
Days Payables Outstanding359.77449.63834.3317.64K21.41K--1.94K3.73K4.65K5.03K5.53K5.39K-2.63K2.84K3.41K3.54K3.23K2.83K
Short-Term Debt176.17K01M1M1M00241.55K235.58K229.73K224K0212.87K0202.18K0191.9K186.92K00
Deferred Revenue (Current)00000000000000000000
Other Current Liabilities43.44M3.6M3.09M3.29M3.71M3.18M2.6M-241.55K1.47M-78.53K2.21M01.39M1.03M1.9M01.11M1.15M3.14M0
Current Ratio0.84x0.58x0.99x0.62x0.47x0.37x0.41x0.40x6.75x5.17x5.06x5.95x7.10x5.62x9.33x9.84x11.40x14.49x9.25x18.28x
Quick Ratio0.40x0.16x0.40x0.13x0.14x0.06x0.09x0.17x6.75x5.17x5.06x5.95x7.10x5.62x9.33x9.84x11.40x14.49x9.25x18.28x
Cash Conversion Cycle625.44683.53776.73-----------------
Total Non-Current Liabilities14.7M8.44M8.72M8.5M8.27M8.03M6.98M6.74M6.65M6.57M6.49M6.4M6.31M6.22M6.13M6.04M5.52M5.57M5.62M5.66M
Long-Term Debt7M0000000000000000000
Capital Lease Obligations0636.67K681.64K724.92K766.96K786.7K021.32K84.43K145.1K204.57K262.87K320.01K374.83K428.57K481.25K532.88K582.3K630.75K678.23K
Deferred Tax Liabilities7.7M7.8M8.04M7.77M7.51M7.24M6.98M6.71M6.57M6.43M6.28M6.14M5.99M5.85M5.71M5.56M4.99M4.99M4.99M4.99M
Other Non-Current Liabilities00000000000000000000
Total Liabilities66.35M63.46M46.92M53.41M60.12M57.91M51.78M42.55M10.81M10.74M12.07M12.18M12.1M12.43M10.67M10.57M9.98M9.59M12.96M9.65M
Total Debt7.18M808.16K1.83M1.81M1.88M931.79K204.57K262.87K320.01K374.83K428.57K481.25K532.88K582.3K630.75K678.23K724.78K769.22K812.77K855.47K
Net Debt-9.83M-3.78M-5.89M-2.44M-4.21M905.38K-895.51K-2.99M-17.59M-12.18M-19.92M-26M-32.75M-28.48M-36.26M-41.03M-47.32M-54.99M-64.61M-69.22M
Debt / Equity0.09x0.01x0.02x0.02x0.03x0.01x0.00x0.00x0.00x0.00x0.01x0.01x0.01x0.01x0.01x0.01x0.01x0.01x0.01x0.01x
Debt / EBITDA--------------------
Net Debt / EBITDA--------------------
Interest Coverage-28.53x-974.68x-57.99x-87.77x-50.90x---------------
Total Equity75.91M69.08M93.47M77.53M67.56M63.58M68.92M74.1M86.28M79.97M85.33M91.43M98.3M91.81M101.03M103.43M110.34M118.2M124.56M132.78M
Equity Growth %12.36%8.66%35.62%4.62%-21.7%-20.5%-19.24%-18.95%-12.22%-12.9%-15.54%-11.6%-10.91%-22.33%-18.89%-22.11%-19.63%-6.02%382.77%294.36%
Book Value per Share2.903.094.354.296.145.495.956.397.447.548.058.639.599.4210.3710.6211.3312.1412.8013.61
Total Shareholders' Equity66.61M61.54M79.96M67.55M65.06M60.66M65.41M70.08M85.68M79.37M84.73M90.83M97.7M91.21M100.43M102.83M109.74M117.6M123.96M132.18M
Common Stock27.45K22.38K22.38K18.07K14.47K8.76K7.73K7.25K180.72K159.09K158.97K158.86K158.86K146.36K146.21K146.21K146.13K146.13K146.03K145.98K
Retained Earnings-277.12M-268.26M-247.02M-238.8M-230.84M-222.05M-211.14M-201.37M-190.58M-180.01M-171.46M-162.23M-152.29M-143.81M-133.28M-129.69M-121.7M-112.83M-105.27M-96.05M
Treasury Stock00000000000000000000
Accumulated OCI00000000000000000000
Minority Interest9.3M7.54M13.51M9.98M2.5M2.92M3.51M4.02M600.38K600.38K600.38K600.38K600.38K600.38K600.38K600.38K600.38K600.38K600.38K600.38K